All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-WFY0002 | Anti-AGO2 (1B1-E2H5) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 1B1-E2H5 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0003 | Anti-AGO2 (2E12-1C9) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 2E12-1C9 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0004 | Anti-AGO2 (CBFYE-0299) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Monkey, Mouse, Rat | CBFYE-0299 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0005 | Anti-AGO2 (CBFYE-0300) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse | CBFYE-0300 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0006 | Anti-AGO2 (CBFYE-0301) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-0301 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0771 | Anti-AGO2 (CBFYH-0006) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-0006 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3255 | Anti-AGO2 (1B1-E2H5) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 1B1-E2H5 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3256 | Anti-AGO2 (2E12-1C9) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 2E12-1C9 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3257 | Anti-AGO2 (CBFYE-0299) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Monkey, Mouse, Rat | CBFYE-0299 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3258 | Anti-AGO2 (CBFYE-0300) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse | CBFYE-0300 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3259 | Anti-AGO2 (CBFYE-0301) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-0301 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY4024 | Anti-AGO2 (CBFYH-0006) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-0006 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION